| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10215295 | Brain and Development | 2018 | 7 Pages |
Abstract
Our results suggest that 1) the efficacy of fPHT and cMDL is similar, although cMDL may prevent the need for BCT compared with fPHT, and 2) fPHT is relatively safe as a second-line treatment for pediatric SE in patients who do not require BCT.
Keywords
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
Masahiro Nishiyama, Hiroaki Nagase, Kazumi Tomioka, Tsukasa Tanaka, Hiroshi Yamaguchi, Yusuke Ishida, Daisaku Toyoshima, Kyoko Fujita, Azusa Maruyama, Hiroshi Kurosawa, Yoshiyuki Uetani, Kandai Nozu, Mariko Taniguchi-Ikeda, Ichiro Morioka,